Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086944
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2004-07-08
Brief Title:
Oblimersen Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Mantle Cell Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
Keywords: